Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: DaiS who wrote (21411)	4/26/1999 5:55:00 PM
From: the student	Read Replies (1) \| Respond to of 23519

I agree about being sceptic but to quote directly from the story..... "It's potentially a $5-billion-a-year market," contends Dr. Michael Wysor, who along with his wife, Dr. Wanda Drinnon Wysor, patented an ointment this month that when applied to the clitoris, the inventors say, can induce multiple orgasms in women. Michael Wysor, who is based in Knoxville, Tenn., and who specializes in treating impotence, said of the ointment: "It increases blood flow tremendously and basically eliminates the need for foreplay. This is going to have an impact equal to that seen with the introduction of the Pill." "Multiple orgasms", "eliminates need for foreplay", "impact equal to the introduction of the Pill" are pretty enthusiastic statements to be equated with " good results" as I characterized them. Of course one can doubt their truthfulness but logically no one with any sense would go through the trouble of patent registration etc. unless himself or herself impressed with the results.